Equity Overview
Price & Market Data
Price: $28.51
Daily Change: +$0.49 / 1.72%
Range: $27.98 - $28.51
Market Cap: $0
Volume: 32,959
Performance Metrics
1 Week: 9.87%
1 Month: -5.81%
3 Months: -12.34%
6 Months: -27.44%
1 Year: -10.65%
YTD: -13.68%
Details
The fund employs a "passive management" - or indexing - investment approach designed to track the performance of the underlying index. It will normally invest at least 80% of its net assets in securities that comprise the underlying index. The underlying index is comprised of small and mid-cap stocks of biotechnology companies that have one or more drugs in either Phase II or Phase III of the U.S. Food and Drug Administration clinical trials.